AI-READI consortium launches groundbreaking diabetes data study

Researchers today (Nov. 8, 2024) are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes.

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled

June 3, 2024

AD/PD 2024: BioVie’s novel NE3107 shows promise but confirmatory trial needed – Pharmaceutical Technology

Share this article On 8 March, at the AD/PD 2024 International Conference on Alzheimer’s and Parkinson’s Diseases, during a symposium titled “Therapeutic Intervention in AD

March 11, 2024

Novacyt makes cash offer for fellow UK diagnostics company as Covid-19 testing revenue dwindles

Novacyt made a cash offer for molecular diagnostics and screening solutions company Yourgene Health as it adjusts from a major drop in revenue due to

July 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.